• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国际前列腺症状评分排尿-储尿分项比值对男性下尿路症状的诊断价值。

Diagnostic value of International Prostate Symptom Score voiding-to-storage subscore ratio in male lower urinary tract symptoms.

机构信息

Department of Urology, Cardinal Tien Hospital and Fu-Jen Catholic University, Taipei, Taiwan.

出版信息

Int J Clin Pract. 2011 May;65(5):552-8. doi: 10.1111/j.1742-1241.2011.02638.x.

DOI:10.1111/j.1742-1241.2011.02638.x
PMID:21489080
Abstract

AIMS

To investigate the diagnostic value of the International Prostate Symptom Score (IPSS) voiding-to-storage subscore ratio (IPSS-V/S) in male lower urinary tract symptoms (LUTS).

METHODS

A total of 253 men with LUTS were enrolled from January 2005 to July 2010. The voiding (IPSS-V) and storage IPSS (IPSS-S) subscores were recorded separately by the patients themselves. The IPSS-V/S was calculated and compared among various aetiologies based on videourodynamic studies. Receiver operating characteristics (ROC) curves were constructed for comparing the diagnostic value of various non-invasive methods for predicting failure to voiding and storage lower urinary tract dysfunction (LUTD).

RESULTS

Patients with failure to voiding LUTD, including benign prostatic obstruction (n = 72), bladder neck dysfunction (n = 19), urethral stricture (n = 3) and poor relaxation of the urethral sphincter (n = 32), had mean IPSS-V/S scores > 1. In contrast, patients who were urodynamically normal (n = 2) or had failure to storage LUTD, including idiopathic detrusor overactivity (n = 84), increased bladder sensation (n = 37), and detrusor overactivity and impaired contractility (n = 4), had IPSS-V/S scores ≤ 1. When IPSS-V/S was used to differentiate male LUTS, failure to voiding LUTD was found in 81.2% of patients with IPSS scores > 1, while failure to storage LUTD was found in 75.7% of patients with IPSS-V/S ≤ 1. The area under ROC curve of IPSS-V/S was higher than for other non-invasive methods for predicting failure to voiding and storage LUTD.

CONCLUSION

Measuring IPSS subscores and calculating IPSS-V/S is a simple and useful method to differentiate failure to voiding and failure to storage LUTD in men with LUTS. IPSS-V/S may provide a guide for the initial treatment, especially for primary care physicians without access to urological studies.

摘要

目的

探讨国际前列腺症状评分(IPSS)排尿-储尿分项评分比值(IPSS-V/S)在男性下尿路症状(LUTS)中的诊断价值。

方法

2005 年 1 月至 2010 年 7 月,共纳入 253 例 LUTS 男性患者。由患者本人分别记录排尿(IPSS-V)和储尿 IPSS(IPSS-S)分项评分。根据尿动力学研究,计算并比较各种病因的 IPSS-V/S。构建受试者工作特征(ROC)曲线,比较各种非侵入性方法预测排尿失败和储尿下尿路功能障碍(LUTD)的诊断价值。

结果

排尿失败 LUTD 患者,包括良性前列腺增生症(n=72)、膀胱颈功能障碍(n=19)、尿道狭窄(n=3)和尿道括约肌松弛不良(n=32),其平均 IPSS-V/S 评分>1。相反,尿动力学正常(n=2)或储尿失败 LUTD 患者,包括特发性逼尿肌过度活动症(n=84)、膀胱感觉增加(n=37)和逼尿肌过度活动伴收缩力受损(n=4),其 IPSS-V/S 评分≤1。当使用 IPSS-V/S 区分男性 LUTS 时,IPSS 评分>1 的患者中 81.2%存在排尿失败 LUTD,而 IPSS-V/S≤1 的患者中 75.7%存在储尿失败 LUTD。IPSS-V/S 的 ROC 曲线下面积高于其他预测排尿和储尿失败 LUTD 的非侵入性方法。

结论

测量 IPSS 分项评分并计算 IPSS-V/S 是区分男性 LUTS 患者排尿失败和储尿失败的简单而有用的方法。IPSS-V/S 可能为初始治疗提供指导,特别是对于无法进行泌尿科研究的初级保健医生。

相似文献

1
Diagnostic value of International Prostate Symptom Score voiding-to-storage subscore ratio in male lower urinary tract symptoms.国际前列腺症状评分排尿-储尿分项比值对男性下尿路症状的诊断价值。
Int J Clin Pract. 2011 May;65(5):552-8. doi: 10.1111/j.1742-1241.2011.02638.x.
2
Severity of lower urinary tract symptoms reflects different composition of bladder storage dysfunction and bladder outlet obstruction in men with symptomatic benign prostatic hyperplasia.有症状的良性前列腺增生男性下尿路症状的严重程度反映了膀胱储尿功能障碍和膀胱出口梗阻的不同构成。
Int J Clin Pract. 2014 Jun;68(6):743-8. doi: 10.1111/ijcp.12364. Epub 2014 Jan 29.
3
International Prostate Symptom Score for assessing lower urinary tract dysfunction in women.用于评估女性下尿路功能障碍的国际前列腺症状评分
Int Urogynecol J. 2013 Feb;24(2):263-7. doi: 10.1007/s00192-012-1818-8. Epub 2012 May 16.
4
Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.在患有下尿路症状和膀胱过度活动症的男性中,使用或不使用坦索罗辛的缓释托特罗定:对通过国际前列腺症状评分评估的泌尿症状的影响。
BJU Int. 2008 Nov;102(9):1133-9. doi: 10.1111/j.1464-410X.2008.07761.x. Epub 2008 May 26.
5
Therapeutic effect of α-blockers and antimuscarinics in male lower urinary tract symptoms based on the International Prostate Symptom Score subscore ratio.基于国际前列腺症状评分亚评分比值的 α 受体阻滞剂和抗胆碱能药物对男性下尿路症状的治疗效果。
Int J Clin Pract. 2012 Feb;66(2):139-45. doi: 10.1111/j.1742-1241.2011.02864.x.
6
International Prostatic Symptom Score-voiding/storage subscore ratio in association with total prostatic volume and maximum flow rate is diagnostic of bladder outlet-related lower urinary tract dysfunction in men with lower urinary tract symptoms.国际前列腺症状评分-排尿/储尿分项评分与前列腺总体积和最大尿流率比值与与膀胱出口相关的下尿路功能障碍相关,可用于诊断有下尿路症状的男性。
PLoS One. 2013;8(3):e59176. doi: 10.1371/journal.pone.0059176. Epub 2013 Mar 18.
7
Effect of tadalafil on male lower urinary tract symptoms: an integrated analysis of storage and voiding international prostate symptom subscores from four randomised controlled trials.他达拉非对男性下尿路症状的影响:四项随机对照试验中储存和排空国际前列腺症状评分子评分的综合分析。
Eur Urol. 2015 Jan;67(1):114-122. doi: 10.1016/j.eururo.2014.08.072. Epub 2014 Oct 7.
8
Videourodynamic analysis of pathophysiology of men with both storage and voiding lower urinary tract symptoms.具有储尿期和排尿期下尿路症状男性患者病理生理学的视频尿动力学分析
Urology. 2007 Aug;70(2):272-6. doi: 10.1016/j.urology.2007.03.063.
9
Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score.国际前列腺症状评分和核心下尿路症状评分评估男性下尿路症状。
BJU Int. 2012 May;109(10):1512-6. doi: 10.1111/j.1464-410X.2011.10445.x. Epub 2011 Aug 26.
10
Evaluation of the clinical value of a simple flowmeter in the management of male lower urinary tract symptoms.评价一种简易流量计在男性下尿路症状管理中的临床价值。
BJU Int. 2012 Jun;109(11):1690-6. doi: 10.1111/j.1464-410X.2011.10581.x. Epub 2011 Sep 20.

引用本文的文献

1
Natural history of lower urinary tract symptoms and voiding parameters in ageing men with 5-year follow-up-the concord health and ageing in men project (CHAMP).老年男性下尿路症状和排尿参数的自然史:5年随访——男性健康与衰老一致性项目(CHAMP)
Age Ageing. 2025 Mar 28;54(4). doi: 10.1093/ageing/afaf078.
2
Add-on or switch to vibegron in patients with overactive bladder insufficiently responding to initial 4-week antimuscarinics: a randomised, parallel-group, multicentre trial () .对初始4周抗毒蕈碱药物治疗反应不足的膀胱过度活动症患者,加用或换用维贝格隆:一项随机、平行组、多中心试验() 。
BMJ Open. 2025 Mar 24;15(3):e094230. doi: 10.1136/bmjopen-2024-094230.
3
Predicting surgical efficacy and diagnosing histological inflammation: the clinical significance of prostate exosome proteins in benign prostatic hyperplasia.
预测手术疗效及诊断组织学炎症:前列腺外泌体蛋白在良性前列腺增生中的临床意义
Transl Androl Urol. 2024 Jun 30;13(6):930-939. doi: 10.21037/tau-23-655. Epub 2024 Jun 13.
4
Diabetes mellitus-induced lower urinary tract symptoms and hepatic steatosis in an older male.老年男性糖尿病诱发的下尿路症状和肝脂肪变性
Endocrinol Diabetes Metab Case Rep. 2022 Sep 1;2022. doi: 10.1530/EDM-22-0290.
5
Type D Personality Is an Independent Predictor of Lower Urinary Tract Symptoms in Young Men.D型人格是年轻男性下尿路症状的独立预测因素。
Front Psychol. 2022 Feb 22;13:822490. doi: 10.3389/fpsyg.2022.822490. eCollection 2022.
6
Impact on quality of life 3 years after diagnosis of prostate cancer patients below 75 at diagnosis: an observational case-control study.诊断时年龄低于 75 岁的前列腺癌患者诊断后 3 年的生活质量影响:一项观察性病例对照研究。
BMC Cancer. 2020 Aug 12;20(1):757. doi: 10.1186/s12885-020-07244-y.
7
Precision medicine in the diagnosis and treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia.精准医学在疑似良性前列腺增生的男性下尿路症状诊断与治疗中的应用
Tzu Chi Med J. 2019 Aug 21;32(1):5-13. doi: 10.4103/tcmj.tcmj_107_19. eCollection 2020 Jan-Mar.
8
Super early detailed assessment of lower urinary tract symptoms after holmium laser enucleation of the prostate (HoLEP): a prospective study.钬激光前列腺剜除术(HoLEP)后下尿路症状的超早期详细评估:一项前瞻性研究
World J Urol. 2020 Dec;38(12):3207-3217. doi: 10.1007/s00345-020-03126-x. Epub 2020 Feb 21.
9
The Therapeutic Effects and Pathophysiology of Botulinum Toxin A on Voiding Dysfunction Due to Urethral Sphincter Dysfunction.肉毒毒素 A 治疗尿道括约肌功能障碍性排尿功能障碍的疗效及发病机制。
Toxins (Basel). 2019 Dec 13;11(12):728. doi: 10.3390/toxins11120728.
10
The effects of statins on benign prostatic hyperplasia and the lower urinary tract symptoms: A Meta-analysis.他汀类药物对良性前列腺增生和下尿路症状的影响:一项Meta分析。
Medicine (Baltimore). 2019 May;98(18):e15502. doi: 10.1097/MD.0000000000015502.